Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Blood Simpling

Reference number
Coordinator Blood Simpling AB
Funding from Vinnova SEK 300 000
Project duration October 2023 - May 2024
Status Completed
Venture Innovative Startups
Call Innovative Impact Startups autumn 2023

Important results from the project

The project goals have been achieved through testing and adjustments of the prototype as well as verification and validation. We have also deepened our understanding of customer benefits, market needs, and purchasing processes, which has strengthened our market strategy and the product´s potential.

Expected long term effects

The result of the project is a prototype where key steps have been developed, verified, and validated. Expected effects include increased customer benefits, better market adaptation, and a stronger market position. The project has also contributed to a deeper understanding of market needs and purchasing processes.

Approach and implementation

The structure and execution of the project involved a systematic development process focused on testing, verification, and validation of the prototype. Regular feedback from users and experts allowed us to adjust and improve the design. Additionally, market analyses were conducted to ensure the product meets customer needs and requirements, strengthening our development strategy.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 28 June 2024

Reference number 2023-02200